Adaptive Biotechnologies Corporation · NASDAQ:ADPT

Bobulsky Susan sold 5,000 Adaptive Biotechnologies Corporation shares (Form 4)

Traded Jun 25, 2026 · Filed Jun 29, 2026

On Jun 25, 2026, Bobulsky Susan (Chief Commercial Officer, MRD) sold 5,000 Adaptive Biotechnologies Corporation shares at US$20.50 for US$103K under a trading plan, leaving 406,775 shares. Filed Jun 29, 2026 (Form 4).

Sold
5,000 shares
Price
US$20.50
Value
US$103K
Holding after
406,775 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Commercial Officer, MRD

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 25, 2026Common StockSale5,000US$20.50406,775Direct

Source

View original at SEC

Related